S100A8 and S100A9 in hematologic malignancies: From development to therapy

Authors

Farnaz Razmkhah, Washington University School of Medicine in St. Louis
Sena Kim, Washington University School of Medicine in St. Louis
Sora Lim, Washington University School of Medicine in St. Louis
Abdul-Jalil Dania, Washington University School of Medicine in St. Louis
Jaebok Choi, Washington University School of Medicine in St. Louis

Journal

International Journal of Molecular Sciences

Publication Date

8-29-2023

Volume

24

Issue

17

First Page

13382

Document Type

Open Access Publication

DOI

10.3390/ijms241713382

Rights and Permissions

Razmkhah F, Kim S, Lim S, Dania AJ, Choi J. S100A8 and S100A9 in Hematologic Malignancies: From Development to Therapy. Int J Mol Sci. 2023 Aug 29;24(17):13382. doi: 10.3390/ijms241713382 Copyright: © 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

Recommended Citation

Razmkhah, Farnaz; Kim, Sena; Lim, Sora; Dania, Abdul-Jalil; and Choi, Jaebok, "S100A8 and S100A9 in hematologic malignancies: From development to therapy." International Journal of Molecular Sciences. 24, 17. 13382 (2023).
https://digitalcommons.wustl.edu/oa_4/4242

Department

ICTS (Institute of Clinical and Translational Sciences)